Response to Letter to the Editor: “Efficacy and Safety of Combination Therapy With Low Dose of Telmisartan and S-Amlodipine in Patients With Hypertension: A Randomized, Double-Blind, Multicenter, Therapeutic Confirmatory, Phase III Clinical Trial”

Sang Hyun Lee, Jinho Shin

Open source

DOI
10.1016/j.clinthera.2026.05.015
Published
2026-07
Container
Clinical Therapeutics
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.clinthera.2026.05.015,
  title = {Response to Letter to the Editor: “Efficacy and Safety of Combination Therapy With Low Dose of Telmisartan and S-Amlodipine in Patients With Hypertension: A Randomized, Double-Blind, Multicenter, Therapeutic Confirmatory, Phase III Clinical Trial”},
  author = {Sang Hyun Lee and Jinho Shin},
  year = {2026},
  journal = {Clinical Therapeutics},
  doi = {10.1016/j.clinthera.2026.05.015},
  url = {https://doi.org/10.1016/j.clinthera.2026.05.015}
}

RIS

TY  - JOUR
TI  - Response to Letter to the Editor: “Efficacy and Safety of Combination Therapy With Low Dose of Telmisartan and S-Amlodipine in Patients With Hypertension: A Randomized, Double-Blind, Multicenter, Therapeutic Confirmatory, Phase III Clinical Trial”
AU  - Sang Hyun Lee
AU  - Jinho Shin
PY  - 2026
JO  - Clinical Therapeutics
DO  - 10.1016/j.clinthera.2026.05.015
UR  - https://doi.org/10.1016/j.clinthera.2026.05.015
ER  - 

APA

Lee, S. H., & Shin, J. (2026). Response to Letter to the Editor: “Efficacy and Safety of Combination Therapy With Low Dose of Telmisartan and S-Amlodipine in Patients With Hypertension: A Randomized, Double-Blind, Multicenter, Therapeutic Confirmatory, Phase III Clinical Trial”. Clinical Therapeutics. https://doi.org/10.1016/j.clinthera.2026.05.015

Source records